Who is Hikma? It’s simple. We create high-quality medicines and make them accessible to the people who need them. That’s what we do.
Its what every one of our 9,400+ employees helps us to do. It’s what we’ve always done… ever since we began almost 50 years ago. Today, our headquarters are in London, but you will also find us in North America, Europe and the MENA region. With 3 main R&D locations, 29 manufacturing plants, with an established commercial infrastructure in our markets, we are global experts with a local presence. Across our sites we’re developing, manufacturing, and making available high-quality medicines for healthcare professionals and patients. 825+ products worldwide (as of Feb 2026) billions of doses annually.
Living our culture of progress and belonging.
Delivering our strategy.
Acting responsibly.
We turn cutting-edge science into innovative everyday solutions that transform people’s lives and make the world healthier.
Committed to quality.
Committed to people.
Committed to better health.
Better health. Within reach. Every day. We are Hikma
Discover what drives us
Latest news
Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes
- Hikma reiterates full year 2026 guidance following encouraging start to the year Press Release, Financial Results 23 April 2026 Hikma reiterates full year 2026 guidance following encouraging start to the year
- Putting patients first through quality: a Q&A with Tyson Ardo, Associate Vice President, Quality Story, Life at Hikma 16 April 2026 Putting patients first through quality: a Q&A with Tyson Ardo, Associate Vice President, Quality
- Investing in R&D to drive high-value pipeline delivery Insight, Report Case Study 18 March 2026 Investing in R&D to drive high-value pipeline delivery
- Investing in manufacturing excellence at Hikma Insight, Report Case Study 18 March 2026 Investing in manufacturing excellence at Hikma
